Yanfeng Gao

100 Kexue Avenue
Zhengzhou, 450001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Development of a lymph node-homing peptide vaccine targeting C-C chemokine receptor 7-positive dendritic cells with enhanced antitumor immunity.

Development of a lymph node-homing peptide vaccine targeting C-C chemokine receptor 7-positive dendritic cells with enhanced antitumor immunity.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: September 17, 2025

An oral vaccine based on stable peptide-chitosan conjugate targeting DEC-205 for cancer immunotherapy.

An oral vaccine based on stable peptide-chitosan conjugate targeting DEC-205 for cancer immunotherapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: August 07, 2025

Design of a bispecific peptide-nanozyme conjugate for cancer immunotherapy.

Design of a bispecific peptide-nanozyme conjugate for cancer immunotherapy.

Journal: Cell reports. Medicine

Published: June 02, 2025

In vitro screening methods of novel immune checkpoint inhibitors related to T cell infiltration and anti-PD-1 resistance.

In vitro screening methods of novel immune checkpoint inhibitors related to T cell infiltration and anti-PD-1 resistance.

Journal: Methods in cell biology

Published: November 08, 2024

Chidamide functions as a VISTA/PSGL-1 blocker for cancer immunotherapy.

Chidamide functions as a VISTA/PSGL-1 blocker for cancer immunotherapy.

Journal: Cancer immunology, immunotherapy : CII

Published: October 08, 2024

A novel peptide targeting CCR7 inhibits tumor cell lymph node metastasis.

A novel peptide targeting CCR7 inhibits tumor cell lymph node metastasis.

Journal: Cancer immunology, immunotherapy : CII

Published: August 27, 2024

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy.

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy.

Journal: Nature communications

Published: July 05, 2024

Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy.

Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 22, 2024

An integrated framework for prognosis prediction and drug response modeling in colorectal liver metastasis drug discovery.

An integrated framework for prognosis prediction and drug response modeling in colorectal liver metastasis drug discovery.

Journal: Journal of translational medicine

Published: October 25, 2023

The scaffold protein AXIN1: gene ontology, signal network, and physiological function.

The scaffold protein AXIN1: gene ontology, signal network, and physiological function.

Journal: Cell communication and signaling : CCS

Published: October 23, 2023

Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy.

Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy.

Journal: Cell communication and signaling : CCS

Published: August 21, 2023

Hemin blocks TIGIT/PVR interaction and induces ferroptosis to elicit synergistic effects of cancer immunotherapy.

Hemin blocks TIGIT/PVR interaction and induces ferroptosis to elicit synergistic effects of cancer immunotherapy.

Journal: Science China. Life sciences

Published: August 13, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026